Has been working as a senior researcher at the Department of Noncommunicable Diseases Clinical Pharmacology and Pharmacogenetics since 2004.
The main field of scientific activity is the influence of pharmacogenetic factors on the heart failure course and the therapy efficiency.
He is studying of the features of the heart failure course in patients with the “low triiodothyronine” syndrome.
Clinical interests are cardiac rhythm and conduction disorders, heart failure.
